4-Aminothiazolyl analogues of GE2270 A: Antibacterial lead finding

Journal of Medicinal Chemistry

Volumn 54, Issue 7, 2011, Pages 2517-2521

  Lamarche, Matthew J ^a   Leeds, Jennifer A ^b   Dzink Fox, Joanne ^b   Gunderson, Karl ^a   Krastel, Philipp ^c   Memmert, Klaus ^c   Patane, Michael A ^a   Rann, Elin M ^a   Schmitt, Esther ^c   Tiamfook, Stacey ^b   Wang, Bing ^a  

^a Global Discovery Chemistry   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOTHIAZOLE DERIVATIVE; AMIDE; ANTIINFECTIVE AGENT; AZIDE; GE 2270A; PICOLINAMIDE; SULFONAMIDE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG DECOMPOSITION; DRUG DESIGN; DRUG POTENCY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG DISCOVERY; DRUG STABILITY; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 79953793161     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101602q     Document Type: Article

References (30)

1. Selva, E.; Beretta, G.; Montanini, N.; Saddler, G. S.; Gastaldo, L.; Ferrari, P.; Lorenzetti, R.; Landini, P.; Ripamonti, F.; Goldstein, B. P.; Berti, M.; Montanaro, I.; Denaro, M. J. Antibiot. 1991, 44 (7) 693-701
2. The structure was later corrected and verified: Tavecchia, P.; Gentili, P.; Kurz, M.; Sottani, C.; Bonfichi, R.; Selva, E.; Lociuro, S.; Restelli, E.; Ciabatti, R. Tetrahedron 1995, 51 (16) 4867-4890. For acidic decomposition, see above
3. For a review of thiopeptide natural products see: Bagley, M. C.; Dale, J. W.; Merritt, E. A.; Xiong, X. Chem. Rev. 2005, 105, 685-714
4. Rezanka, T.; Sobotka, M.; Spizek, J.; Sigler, K. Anti-Infect. Agents Med. Chem., 2006, 5, 187-224.
5. Hughs, R. A.; Moody, C. J. Angew. Chem., Int. Ed. 2007, 46, 2-27
6. Thiostrepton: Mocek, U.; Zeng, Z.; O'Hagan, D.; Zhou, P.; Fan, L. D. G.; Beale, J. M.; Floss, H. G. J. Am. Chem. Soc. 1993, 115, 7992-8001
7. Nocathiocins: Pucci, M. A.; Bronson, J. J.; Barret, J. F.; DenBleyker, K. L.; Driscotto, L. F.; Fung-Tomc, J. C.; Ueda, Y. Antimicrob. Agents Chemother. 2004, 48, 3697-3701
8. Naidu, B. N.; Sorensen, M. E.; Bronson, J. J.; Pucci, M. J.; Clark, J. M.; Ueda, Y. Bioorg. Med. Chem. Lett. 2005, 15, 2069-2072 and references cited therein
9. Amythiomicins: Shiminaka, K.; Kinoshita, N.; Iinuba, H.; Hamada, M.; Takeuchi, T. J. Antibiot. 1994, 47 (6) 668-674
10. Thiomuracins: Morris, R. P.; Leeds, J. A.; Naegeli, H. U.; Oberer, L.; Memmert, K.; Weber, E.; LaMarche, M. J.; Parker, C. N.; Burrer, N.; Esterow, S.; Hein, A. E.; Schmitt, E. K.; Krastel, P. J. Am. Chem. Soc. 2009, 131, 5946-5955
11. For review of the elongation factors see: Lim, V. I.; Curran, J. F.; Garber, M. B. J. Mol. Biol. 2005, 351, 470-480
12. Nilsson, J.; Nissen, P. Curr. Opin. Struct. Biol. 2005, 15, 349-354
13. Clough, J.; Chen, S.; Gordon, E. M.; Hackbarth, C.; Lam, S.; Trias, J.; White, R. J.; Candiani, G.; Donadio, S.; Romano, G.; Ciabatti, R.; Jacobs, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 3409-3414
14. Malabarba, M.; Cavaleri, M.; Mosconi, G.; Jabes, D.; Romano, G. Patent WO 2003105881, 2003.
15. Tavecchia, P.; Kurz, M.; Colombo, L.; Bonofichi, R.; Selva, E.; Lociuro, S.; Marzorati, E.; Ciabatti, R. Tetrahedron 1996, 52 (26) 8763-8774
16. Butler, M. S. Nat. Prod. Rep. 2005, 22, 162-195
17. Heckmann, G.; Bach, T. Angew. Chem., Int. Ed. 2005, 44, 1199-1201
18. Nicolaou, K. C.; Zou, B.; Dethe, D. H.; Li, D. B.; Chen, D. Y. K. Angew. Chem., Int. Ed. 2006, 45, 7786-7792
19. Heffron, S. E.; Jurnak, F. Biochemistry 2000, 39, 37-45
20. Heffron, S. E.; Moeller, R.; Jurnak, F. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2006, D62, 433-438
21. Parmeggiani, A.; Nissen, P. FEBS Lett. 2006, 580, 4576-4581
22. Lewis, R. J.; Hughs, R. A.; Alcaraz, L.; Thompson, S. P.; Moody, C. J. Chem. Commun. 2006, 4215-4217
23. Poulakou, G.; Giamarellou, H. Expert Opin. Invest. Drugs 2007, 16 (2) 137-155
24. A bacterial inhibition screen measuring growth inhibition of S. aureus at a single concentration was conducted on the entire Novartis compound archive (>600000 compounds).
25. GE2270 and fermentation metabolites were isolated from a rare strain of Actinomycetes, Nonomuraea strain WU8817.
26. South, M. S. J. Heterocycl. Chem. 1991, 28, 1003
27. Larsen, S. D.; Stachew, C. F.; Claire, P. M.; Cubbage, J. W.; Leach, K. L. Bioorg. Med. Chem. Lett. 2003, 13, 3491-3495
28. Green, J.; Miller, A.; Jiminez, J. M.; Marhefka, C.; Cao, J.; Court, J. J.; Bandarage, U. K.; Gao, K.; Nanthakumar, S., WO2005/103050, 2005.
29. MIC assays were conducted according to the Clinical and Laboratory Standards Institute (CLSI). Wikler, M. A.; Cockerill, F. R.; Bush, K, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 8th ed.; Clinical and Laboratory Standards Institute: Wayne, PA, 2009; Vol. 29, no. 2, CLSI M07-A8. Bacterial strains included E. faecalis (ATCC 29212), E. faecium (Prof. Chopra, University of Leeds UK, strain 7130724), S. aureus (MRSA from Prof. Willinger, isolated from a pharyngeal smear, AKH Vienna A4.018), S. pyogenes (ATCC BAA-595).
30. Wikler, M. A., Cockerill, F. R., Bush, K., Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement; Clinical and Laboratory Standards Institute: Wayne, PA, 2009; Vol. 29, no. 3, CLSI M100-S19.